Cradle Platform from Cradle Bio is an artificial intelligence system that trains custom models on laboratory results to design improved proteins. It optimizes binding, stability, and expression simultaneously while generating de-risked experimental plates each round, validated through a wet-lab loop. Scientist teams use it to compress antibody and enzyme optimization timelines substantially.
The system competes with sequence-based binding predictors by grounding every design cycle in fresh experimental feedback. Cradle delivers the platform through web and API workspaces with provenance tracking, serving pharma and industrial biotechnology programs that measure success in the laboratory.

Cradle Platform is an AI system that engineers proteins from laboratory data.




ProteinBase is an open data hub of validated proteins and design methods.


Biomedical AI platform that grounds biopharma R&D decisions in validated biology.


NucleIQ is Creyon's AI-powered nucleic acid engineering platform for designing oligonucleotide-based medicines.


Atlas is a licensable protein-interaction data ecosystem from A-Alpha Bio for AI-enabled protein design.


Transformer-based AI platform from Atombio for aptamer discovery and optimization in days.


EXIS is Prellis Biologics' AI-driven platform for discovering fully human, low-immunogenicity antibodies.


mBER is Manifold Bio's open-source AI framework for designing antibody binders for in vivo drug discovery.


Cyrus Platform is Cyrus Biotechnology's computational protein design offering combining AI and Rosetta-based design with laboratory mutagenesis screening.


AI-enabled natural-product drug discovery platform organizing plant chemistry into a searchable library with machine-learning translation and automated screening.


Biology-First AI platform predicts disease-matched compounds using multi-omics human data and functional validation.


Generative protein language model family that jointly reasons over protein sequence, structure, and function to design novel proteins.
EvoGen is a generative AI platform that designs novel therapeutic proteins.

HyperBind is an AI antibody design platform that learns from experimental feedback.

ProteinBase is an open data hub of validated proteins and design methods.

Biomedical AI platform that grounds biopharma R&D decisions in validated biology.

NucleIQ is Creyon's AI-powered nucleic acid engineering platform for designing oligonucleotide-based medicines.

Atlas is a licensable protein-interaction data ecosystem from A-Alpha Bio for AI-enabled protein design.

Transformer-based AI platform from Atombio for aptamer discovery and optimization in days.

EXIS is Prellis Biologics' AI-driven platform for discovering fully human, low-immunogenicity antibodies.

mBER is Manifold Bio's open-source AI framework for designing antibody binders for in vivo drug discovery.

Cyrus Platform is Cyrus Biotechnology's computational protein design offering combining AI and Rosetta-based design with laboratory mutagenesis screening.

AI-enabled natural-product drug discovery platform organizing plant chemistry into a searchable library with machine-learning translation and automated screening.

Biology-First AI platform predicts disease-matched compounds using multi-omics human data and functional validation.

Generative protein language model family that jointly reasons over protein sequence, structure, and function to design novel proteins.
